Paper2364366
Clinical course of essential thrombocythemia in 147 cases.
Fenaux P and 5 others. Cancer, 1990. Cited by 260 papers, by iCite.
Cite this record
ConductScience Library. Clinical course of essential thrombocythemia in 147 cases. Papers, record 2364366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2364366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Thrombocythemia, Essential | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Remission Induction | |
| Thrombosis |
Source PubMed
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 260 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41070066 | VFM-SSL-BMADCC-Framework: vision foundation model and self-supervised learning based automated framework for differential cell counts on whole-slide bone marrow aspirate smears. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41070066 | PubMed |
| 39434013 | Newly diagnosed essential thrombocythemia leading to cardiogenic shock: a case report. | BMC Cardiovasc Disord | 2024 | https://conductscience.org/library/papers/39434013 | PubMed |
| 39053144 | Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events. | Clin Appl Thromb Hemost | 2024 | https://conductscience.org/library/papers/39053144 | PubMed |
| 37621813 | Toe Gangrene as the First Presenting Symptom of Essential Thrombocythemia: A Case Report. | Cureus | 2023 | https://conductscience.org/library/papers/37621813 | PubMed |
| 37209326 | Allelic burden of Janus kinase 2 in a 6-month course of therapy for myeloproliferative neoplasms. | Mol Biol Rep | 2023 | https://conductscience.org/library/papers/37209326 | PubMed |
| 36979444 | Structural and Dynamic Differences between Calreticulin Mutants Associated with Essential Thrombocythemia. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979444 | PubMed |
| 36654555 | Essential Thrombocytosis in Patients <40 Years Old With Acute Coronary Syndromes: A Not So Uncommon Underlying Diagnosis Often Overlooked. | Cureus | 2022 | https://conductscience.org/library/papers/36654555 | PubMed |
| 36652138 | Risk of thrombosis in essential thrombocythemia according to three prediction models: an external validation study. | J Thromb Thrombolysis | 2023 | https://conductscience.org/library/papers/36652138 | PubMed |
| 36561301 | Clinical characteristics and management of headache in patients with myeloproliferative neoplasms. | Front Neurol | 2022 | https://conductscience.org/library/papers/36561301 | PubMed |
| 36505839 | A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment. | Front Oncol | 2022 | https://conductscience.org/library/papers/36505839 | PubMed |
| 36187505 | A woman presenting with facial droop. | J Am Coll Emerg Physicians Open | 2022 | https://conductscience.org/library/papers/36187505 | PubMed |
| 35162937 | Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35162937 | PubMed |
| 34945099 | Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings? | J Clin Med | 2021 | https://conductscience.org/library/papers/34945099 | PubMed |
| 34507190 | Postoperative bleeding in essential thrombocytosis patients with colorectal cancer: Case report and literature review. | Int J Surg Case Rep | 2021 | https://conductscience.org/library/papers/34507190 | PubMed |
| 34430110 | Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders. | Cureus | 2021 | https://conductscience.org/library/papers/34430110 | PubMed |
| 33849034 | Antithrombotic Management in Ischemic Stroke with Essential Thrombocythemia: Current Evidence and Dilemmas. | Med Princ Pract | 2021 | https://conductscience.org/library/papers/33849034 | PubMed |
| 33824820 | Hemodynamic Instability in Emergency Department: Giant Rectus Sheath Hematoma and Point-of-Care Ultrasonography. | Cureus | 2021 | https://conductscience.org/library/papers/33824820 | PubMed |
| 33147902 | The 2020 revision of the guidelines for the management of myeloproliferative neoplasms. | Korean J Intern Med | 2021 | https://conductscience.org/library/papers/33147902 | PubMed |
| 32121664 | Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32121664 | PubMed |
| 31496912 | Thiol-disulphide Homeostasis in Essential Thrombocythemia Patients. | J Med Biochem | 2019 | https://conductscience.org/library/papers/31496912 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2364366
GET https://conductscience.org/api/papers/v1/2364366/cited_by?page=2